Pregnancy: Pregnancy Category C: In reproductive toxicity studies in rats and rabbits, oral treatment with sumatriptan was associated with embryolethality, fetal abnormalities, and pup mortality. When administered by the intravenous route to rabbits, sumatriptan has been shown to be embryolethal.
There are currently seven oral triptans on the market in the United States: sumatriptan (Imitrex), Triptans are considered category C in pregnancy, so the
Some authors recommend triptans not be given during pregnancy due to the vasoconstricting effects of this category of medications. Sumatriptan
Some authors recommend triptans not be given during pregnancy due to the vasoconstricting effects of this category of medications. Sumatriptan
No data available. 4.6. Fertility, pregnancy and lactation. Pregnancy (Category B3) pregnancy outcomes in over 1,000 women exposed to sumatriptan.
Studies on triptan (pregnancy category C) use during pregnancy has been fairly reassuring. For pregnancies where triptan use is needed, sumatriptan (Imitrex) is usually the first triptan to be prescribed. Sumatriptan has been available longest and has the most safety data.
Advice and warnings for the use of Sumatriptan during pregnancy. FDA Pregnancy Category C - Risk cannot be ruled out.
pregnancy outcomes in approximately 1,100 women exposed to sumatriptan The Use of SUMATRIPTAN During Pregnancy: Do not use SUMATRIPTAN if
Studies on triptan (pregnancy category C) use during pregnancy has been fairly reassuring. For pregnancies where triptan use is needed, sumatriptan (Imitrex) is usually the first triptan to be prescribed. Sumatriptan has been available longest and has the most safety data.
Comments